Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 750
Summary
- Conditions
- Acute Pain
- Back Muscle Spasm
- Back Pain
- Back Spasm Upper
- Back Strain
- Muscle Spasm
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 64 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04671082
- Collaborators
- Not Provided
- Investigators
- Study Director: Randall Kaye, MD Neurana Pharmaceuticals
Get Well Soon